Results 21 to 30 of about 10,827 (201)
Genomic comparisons of Escherichia coli ST131 from Australia
Escherichia coli ST131 is a globally dispersed extraintestinal pathogenic E. coli lineage contributing significantly to hospital and community acquired urinary
Dmitriy Li +17 more
openaire +4 more sources
Background In 2016, a study in a Dutch nursing home showed prolonged colonization duration of extended-spectrum β-lactamase-producing (ESBL)-ST131 compared to ESBL-non-ST131. In this study, we assessed the duration of rectal ESBL-producing E.
Veronica Weterings +6 more
doaj +1 more source
Genotypic and Phenotypic Profiles of Escherichia coli Isolates Belonging to Clinical Sequence Type 131 (ST131), Clinical Non-ST131, and Fecal Non-ST131 Lineages from India [PDF]
ABSTRACT In view of the epidemiological success of CTX-M-15-producing lineages of Escherichia coli and particularly of sequence type 131 (ST131), it is of significant interest to explore its prevalence in countries such as India and to determine if antibiotic resistance, virulence, metabolic potential, and/
Arif, Hussain +5 more
openaire +2 more sources
OmpC regulation differs between ST131 and non-ST131 Escherichia coli clinical isolates and involves differential expression of the small RNA MicC [PDF]
Abstract Background Virulence genes and the expression of resistance mechanisms undoubtedly play a role in the successful spread of the pandemic clone Escherichia coli ST131. Porin down-regulation is a chromosomal mechanism associated with antibiotic resistance.
Suelter, Corey S, Hanson, Nancy D
openaire +2 more sources
Plasmids Shape the Diverse Accessory Resistomes of Escherichia coli ST131 [PDF]
The human gut microbiome includes beneficial, commensal and pathogenic bacteria that possess antimicrobial resistance (AMR) genes and exchange these predominantly through conjugative plasmids. Escherichia coli is a significant component of the gastrointestinal microbiome and is typically non-pathogenic in this niche.
Arun Gonzales Decano +14 more
openaire +3 more sources
Analysis of Human miRNA Derived From Bladder Epithelial Cells Infected With Uropathogenic Escherichia coli. [PDF]
ABSTRACT MicroRNAs (miRNAs) have been shown to regulate many cellular processes and to play a role in host‐pathogen interactions. However, the role of miRNA in urinary tract infection (UTI) remains unclear. The aim of this study was to analyze and compare miRNAs from supernatants of human bladder epithelial cells infected with ESBL‐producing (ESBL019 ...
Persson K, Demirel I, Rangel I, Kruse R.
europepmc +2 more sources
The aim of this study was to identify and compare the plasmid replicons of clinical uropathogenic Escherichia coli (UPEC) isolates, involving extended spectrum β-lactamase (ESBL)-positive and ESBL-negative, E.
Abdulaziz Alangari +3 more
doaj +1 more source
Escherichia coli ST131 producing CTX-M-15 in Australia [PDF]
Sir, Escherichia coli clonal group ST131 has been reported from many parts of the world and is frequently associated with production of CTX-M-type extended-spectrum β-lactamase (ESBL), in particular CTX-M-15.1,2 Clonal group ST131 may be associated with other β-lactamases or may be resistant to fluoroquinolones; some isolates may be cephalosporin ...
Sidjabat, Hanna E +3 more
openaire +3 more sources
Sequence type (ST) 131 is a multidrug-resistant pandemic lineage of E. coli responsible for extraintestinal infections. Few surveillance data of ST131 included all antimicrobial-susceptible and -resistant isolates or focused on community-acquired urinary
Jiun-Ling Wang +10 more
doaj +1 more source
Background: Commensal extended-spectrum β-lactamase (ESBL) producing Escherichia coli isolates in the gut can be the reservoir of virulence factors and resistance genes. Objectives: We investigated the molecular feature, risk factors, and quinolone/fluoroquinolone (Q/FQ) resistance in sequence type 131 (ST131) and non-ST131: ESBL-producing E. coli (EPE)
Azade Hajihasani +4 more
openaire +1 more source

